Huifang Liang, one of the principal investigators at the Liver Surgery Laboratory of Tongji Hospital, Huazhong University of Science and Technology, has published multiple research articles on liver cancer as a corresponding author. These include: "Lactylation-Driven IGF2BP3-Mediated Serine Metabolism Reprogramming and RNA m6A-Modification Promotes Lenvatinib Resistance in HCC"; "Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma"; and "Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression," among others.